Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jul 24, 2015- Praluent available early next week to U.S. patients -
-
Jul 14, 2015- Leading influenza vaccine manufacturer to distribute more than 65 million doses to help protect people six months and older against the flu -
-
Jun 30, 2015Sanofi and Regeneron Engage Academy Award® Winning Documentarian to Capture Behind-the-Scenes Look at Life with an Invisible Condition
-
Jun 8, 2015- ELIXA is the first event-driven cardiovascular outcomes study to provide data for a GLP-1 receptor agonist -
-
May 21, 2015- Includes study in patients who were inadequate responders to, or intolerant of, TNF-alpha inhibitors -
-
May 18, 2015- Phase 3 Clinical Trial in Uncontrolled Persistent Asthma Underway -
-
May 11, 2015Despite CDC recommendations, fewer than 30% of teens received the second vaccination to help protect against meningococcal meningitis; new survey reveals potential reasons why
-
Apr 15, 2015U.S. Patent and Trademark Office Honors Sanofi for its Anti-Malarial Treatment
-
Mar 25, 2015Approval allows children to receive a combination of two recommended vaccinations
-
Mar 19, 2015- Results support resubmission of U.S. New Drug Application in Q3 2015 -
-
Mar 18, 2015Allergy sufferers are encouraged to share the #HappySmells they experience this season
-
Mar 15, 2015- Robust and consistent LDL-C lowering demonstrated with Praluent™ in largest, double-blind, placebo-controlled trial of a PCSK9 inhibitor to date -
-
Feb 18, 2015View the Interactive Maps on www.CholesterolCounts.com for a Snapshot of Cholesterol Awareness Across the U.S.
-
Feb 11, 2015America's Leading National Consumer Research Survey Ranks Gold Bond Products #1 in "U.S. Body Comfort and Relief" and "U.S. Skincare" Categories